|
1 |
Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study
Kähler, Katharina C.. - Würzburg : Universität Würzburg, 2025
|
|
|
|
2 |
First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: a multicenter study from the prospective skin cancer registry ADOREG
Reinhard, Sören. - Augsburg : Universität Augsburg, 2025
|
|
|
|
3 |
Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis
Zaremba, Anne. - Würzburg : Universität Würzburg, 2025
|
|
|
|
4 |
Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors
Arnold, Lisa. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2025
|
|
|
|
5 |
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma
Kähler, K. C.. - Augsburg : Universität Augsburg, 2025
|
|
|
|
6 |
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
Koch, Elias A. T.. - Würzburg : Universität Würzburg, 2025
|
|
|
|
7 |
Outcome of systemic therapy in patients with advanced rare skin cancers: a retrospective multicenter DeCOG study of 209 patients
Ugurel, Selma. - Augsburg : Universität Augsburg, 2025
|
|
|
|
8 |
Sex-specific survival in advanced metastatic melanoma – a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG
Leven, Anna-Sophia. - Augsburg : Universität Augsburg, 2025
|
|
|
|
9 |
Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy
Haist, Maximilian. - Leipzig : Universitätsbibliothek Leipzig, 2025
|
|
|
10 |
Development and Evaluation of a Web-Based Outcome Database for Advanced Melanoma with Rare BRAF Mutations
Enthalten in Applied clinical informatics Bd. 16, 2025, Nr. 05: 1541-1549
|
|
Administration
